| scholarly article | Q13442814 |
| P50 | author | Julie E. Buring | Q67224421 |
| Reza Dana | Q16206939 | ||
| P2093 | author name string | Debra A Schaumberg | |
| David A Sullivan | |||
| P2860 | cites work | Impact of antiandrogen treatment on the fatty acid profile of neutral lipids in human meibomian gland secretions. | Q52069655 |
| Survey of preferred tests for diagnosis of the tear film and dry eye. | Q54135549 | ||
| Dry Eye and Dry Mouth in the Elderly | Q58760236 | ||
| Evaluation of ocular surface inflammation in the presence of dry eye and allergic conjunctival disease | Q62116773 | ||
| Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men | Q72810017 | ||
| Frequency of dry eye diagnostic test procedures used in various modes of ophthalmic practice | Q74120729 | ||
| Prevalence of and risk factors for dry eye syndrome | Q74298539 | ||
| Validation and repeatability of a short questionnaire for dry eye syndrome | Q79826261 | ||
| Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions | Q80243890 | ||
| The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) | Q80347907 | ||
| The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007) | Q80347909 | ||
| Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007) | Q80347912 | ||
| Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women | Q24537414 | ||
| Duloxetine in the treatment of major depressive disorder: an open-label study | Q24565020 | ||
| Effect of androgen deficiency on the human meibomian gland and ocular surface | Q28141302 | ||
| Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface? | Q28189953 | ||
| Prevalence of dry eye syndrome among US women | Q28196875 | ||
| Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye | Q28214408 | ||
| Complete androgen insensitivity syndrome: effect on human meibomian gland secretions | Q28216792 | ||
| Final report on the aspirin component of the ongoing Physicians' Health Study | Q29619461 | ||
| Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials | Q33848201 | ||
| Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate | Q33980401 | ||
| The epidemiology of dry eye in Melbourne, Australia | Q34471837 | ||
| Sex steroids, the meibomian gland and evaporative dry eye. | Q35076448 | ||
| Impact of dry eye syndrome on vision-related quality of life | Q35741609 | ||
| Is dehydroepiandrosterone a hormone? | Q36315402 | ||
| Bupropion | Q36669095 | ||
| Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis | Q36888110 | ||
| Prevalence of dry eye among the elderly | Q39457390 | ||
| Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: longitudinal analyses of two geographically separate regional cohorts | Q39802392 | ||
| Expression of muscarinic and adrenergic receptors in normal human conjunctival epithelium. | Q40465476 | ||
| Sebocytes are the key regulators of androgen homeostasis in human skin | Q40806898 | ||
| Hormone replacement therapy and dry eye syndrome | Q43788868 | ||
| Keratoconjunctivitis sicca and primary Sjögren's syndrome in a Danish population aged 30-60 years | Q44997732 | ||
| A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host disease | Q45256597 | ||
| Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye. | Q45950875 | ||
| Long-term incidence of dry eye in an older population | Q46447847 | ||
| Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. | Q50941992 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 763-768 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | JAMA Ophthalmology | Q4787301 |
| P1476 | title | Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies | |
| P478 | volume | 127 |
| Q35956929 | 17-β-estradiol inhibits hyperosmolarity-induced proinflammatory cytokine elevation via the p38 MAPK pathway in human corneal epithelial cells |
| Q38814043 | A Comprehensive Review of Sex Disparities in Symptoms, Pathophysiology, and Epidemiology of Dry Eye Syndrome |
| Q59104204 | A Comprehensive Review on Dry Eye Disease: Diagnosis, Medical Management, Recent Developments, and Future Challenges |
| Q57484944 | A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease |
| Q37676992 | A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye. |
| Q33914344 | A glimpse at the aging eye. |
| Q37780303 | A lacrimal gland is a lacrimal gland, but rodent's and rabbit's are not human. |
| Q34538059 | A mouse dry eye model induced by topical administration of benzalkonium chloride. |
| Q48171815 | A new dry eye mouse model produced by exorbital and intraorbital lacrimal gland excision. |
| Q42160497 | Absence of ductal hyper-keratinization in mouse age-related meibomian gland dysfunction (ARMGD). |
| Q36179631 | Activation of HIF-1α (hypoxia inducible factor-1α) prevents dry eye-induced acinar cell death in the lacrimal gland |
| Q64095333 | Age-related Autoimmune Changes in Lacrimal Glands |
| Q35773063 | Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease |
| Q37737497 | Age-related spontaneous lacrimal keratoconjunctivitis is accompanied by dysfunctional T regulatory cells |
| Q34273593 | Aging and dry eye disease |
| Q34114336 | Aging: a predisposition to dry eyes. |
| Q35094304 | An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye |
| Q48943977 | Anxiety and depression in patients with dry eye syndrome. |
| Q47213405 | Are Serum Vitamin D Levels Associated With Dry Eye Disease? Results From the Study Group for Environmental Eye Disease |
| Q58555493 | Association between Dry Eye Disease, Air Pollution and Weather Changes in Taiwan |
| Q55429072 | Association between dry eye symptoms and suicidal ideation in a Korean adult population. |
| Q33713187 | Association of dry eye disease with psychiatric or neurological disorders in elderly patients |
| Q60934200 | Calcitriol inhibits ROS-NLRP3-IL-1β signaling axis via activation of Nrf2-antioxidant signaling in hyperosmotic stress stimulated human corneal epithelial cells |
| Q50079417 | Calcitriol, the Active Metabolite of Vitamin D3, Inhibits Dry Eye Related Corneal Inflammation In Vivo and In Vitro. |
| Q35555771 | Challenges in the clinical measurement of ocular surface disease in glaucoma patients |
| Q90746682 | Changes in Corneal Detection Thresholds After Repeated Tear Film Instability |
| Q34937035 | Changes in gene expression in human meibomian gland dysfunction |
| Q37458867 | Characteristics of respondents with glaucoma and dry eye in a national panel survey |
| Q36867022 | Characterization of Rat Meibomian Gland Ion and Fluid Transport. |
| Q35040958 | Chemokine receptors CCR6 and CXCR3 are necessary for CD4(+) T cell mediated ocular surface disease in experimental dry eye disease |
| Q37067291 | Chronic dry eye disease is principally mediated by effector memory Th17 cells |
| Q42680792 | Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease. |
| Q49844544 | Comparison Between Viscous Teardrops and Saline Solution to Fill Orthokeratology Contact Lenses Before Overnight Wear. |
| Q89505798 | Comparison of corneal thickness in patients with dry eye disease using the Pentacam rotating Scheimpflug camera and anterior segment optical coherence tomography |
| Q36192148 | Comparison of the Schirmer I test with and without topical anesthesia for diagnosing dry eye |
| Q26752848 | Comprehensive Review of the Literature on Existing Punctal Plugs for the Management of Dry Eye Disease |
| Q37710597 | Computer vision syndrome and associated factors among medical and engineering students in chennai |
| Q37863704 | Computer vision syndrome: a review of ocular causes and potential treatments |
| Q49118814 | Computer-related visual symptoms in office workers. |
| Q36300034 | Conjunctival Goblet Cell Function: Effect of Contact Lens Wear and Cytokines |
| Q50098128 | Corneal Tissue From Dry Eye Donors Leads to Enhanced Graft Rejection. |
| Q37485838 | Corneal sensitivity, ocular surface health and tear film stability after punctal plug therapy of aqueous deficient dry eye. |
| Q38235721 | Current Approach to Dry Eye Disease. |
| Q57378488 | Current and emerging therapy of dry eye disease. Part A: pharmacological modalities |
| Q24169750 | Depression, post-traumatic stress disorder, and dry eye syndrome: a study utilizing the national United States Veterans Affairs administrative database |
| Q35633243 | Detection of BrdU-label retaining cells in the lacrimal gland: implications for tissue repair. |
| Q26746232 | Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease |
| Q37536295 | Discordant Dry Eye Disease (An American Ophthalmological Society Thesis). |
| Q37309500 | Do sex steroids exert sex-specific and/or opposite effects on gene expression in lacrimal and meibomian glands? |
| Q55075449 | Does Dry Eye Affect Repeatability of Corneal Topography Measurements? |
| Q93109216 | Dry Eye Analysis: A Citation Network Study |
| Q64060184 | Dry Eye Disease: Consideration for Women's Health |
| Q34346990 | Dry Eye Disease: Impact on Quality of Life and Vision |
| Q36829070 | Dry Eye Profiles in Patients with a Positive Elevated Surface Matrix Metalloproteinase 9 Point-of-Care Test Versus Negative Patients. |
| Q34647761 | Dry eye as a mucosal autoimmune disease |
| Q34123349 | Dry eye disease |
| Q37756166 | Dry eye disease as an inflammatory disorder |
| Q43929308 | Dry eye disease in French elderly subjects: the Alienor Study |
| Q36916372 | Dry eye disease: an immune-mediated ocular surface disorder |
| Q26770830 | Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review |
| Q36424981 | Effect of Stratification on Surface Properties of Corneal Epithelial Cells |
| Q36758312 | Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis |
| Q35655084 | Effectiveness and relevant factors of 2% rebamipide ophthalmic suspension treatment in dry eye. |
| Q51836466 | Effects of Aging in Dry Eye. |
| Q35732401 | Effects of Dry Eye Therapies on Environmentally Induced Ocular Surface Disease |
| Q89184199 | Effects of PACAP on Dry Eye Symptoms, and Possible Use for Therapeutic Application |
| Q37737978 | Effects of a warm compress containing menthol on the tear film in healthy subjects and dry eye patients. |
| Q36940222 | Efficacy and safety of chondroitin sulfate/xanthan gum versus polyethylene glycol/propylene glycol/hydroxypropyl guar in patients with dry eye. |
| Q40997622 | Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: a Japanese Phase II clinical trial |
| Q53104665 | Efficacy of a New Ocular Surface Modulator in Restoring Epithelial Changes in an In Vitro Model of Dry Eye Syndrome. |
| Q51611085 | Electronic enhancement of tear secretion. |
| Q92340824 | Evaluation of Corneal Damage After Lacrimal Gland Excision in Male and Female Mice |
| Q54081258 | Factors associated with mucosal dryness in multiple regions and skin: A web-based study in women. |
| Q36827562 | Factors predicting the ocular surface response to desiccating environmental stress |
| Q36075268 | Female-Specific Downregulation of Tissue Polymorphonuclear Neutrophils Drives Impaired Regulatory T Cell and Amplified Effector T Cell Responses in Autoimmune Dry Eye Disease |
| Q28274480 | Gene expression in human accessory lacrimal glands of Wolfring |
| Q35030126 | Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients |
| Q33686417 | Image-guided evaluation and monitoring of treatment response in patients with dry eye disease |
| Q24169749 | Impact of ocular surface symptoms on quality of life in a United States Veterans Affairs population |
| Q35050334 | Incidence and pattern of dry eye after cataract surgery |
| Q36591822 | Influence of aromatase absence on the gene expression and histology of the mouse meibomian gland |
| Q48033129 | Influence of selective serotonin reuptake inhibitors on ocular surface |
| Q37662097 | Interferon-gamma deficiency protects against aging-related goblet cell loss. |
| Q35001933 | Interferon-γ-secreting NK cells promote induction of dry eye disease |
| Q90609961 | Involvement of adiponectin in age-related increases in tear production in mice |
| Q89928664 | Kinetics of Corneal Antigen Presenting Cells in Experimental Dry Eye Disease |
| Q100559201 | Lacrimal gland excision in male and female mice causes ocular pain and anxiety-like behaviors |
| Q38261310 | Latanoprost in the treatment of glaucoma |
| Q38608475 | Lifitegrast for the treatment of dry eye disease in adults |
| Q36494967 | Long-term Natural History of Dry Eye Disease from the Patient's Perspective |
| Q36469760 | Longitudinal evidence on punctal plug use in an elderly population |
| Q47437122 | Loss of β Epithelial Sodium Channel Function in Meibomian Glands Produces Pseudohypoaldosteronism 1-Like Ocular Disease in Mice |
| Q42596207 | Meibomian gland morphogenesis requires developmental eyelid closure and lid fusion |
| Q35591394 | Mesenchymal stem/stromal cells protect the ocular surface by suppressing inflammation in an experimental dry eye. |
| Q36097249 | Metabolic syndrome risk factors and dry eye syndrome: a Meta-analysis |
| Q30492030 | Morphology and Function of Meibomian Glands and Other Tear Film Parameters in Junior High School Students |
| Q33752165 | Nanomolar-Potency Aminophenyl-1,3,5-triazine Activators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Channel for Prosecretory Therapy of Dry Eye Diseases |
| Q40062999 | Neuropathic symptoms of the ocular surface: dryness, pain, and itch |
| Q47566745 | Neuropathic-Like Ocular Pain and Nonocular Comorbidities Correlate With Dry Eye Symptoms |
| Q34841120 | Nutrition and age-related eye diseases: the Alienor (Antioxydants, Lipides Essentiels, Nutrition et maladies OculaiRes) Study |
| Q35049903 | Ocular complications of diabetes mellitus |
| Q37605983 | Ocular surface disease and dacryoadenitis in aging C57BL/6 mice. |
| Q35907009 | Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease |
| Q37551864 | Ocular surface symptoms in veterans returning from operation Iraqi freedom and operation enduring freedom |
| Q24198944 | Omega-3 and omega-6 polyunsaturated fatty acids for dry eye syndrome |
| Q34194231 | Omega-3 essential fatty acids therapy for dry eye syndrome: a meta-analysis of randomized controlled studies |
| Q34226122 | Oral administration of royal jelly restores tear secretion capacity in rat blink-suppressed dry eye model by modulating lacrimal gland function |
| Q35126139 | Organization of lipids in the tear film: a molecular-level view |
| Q24186110 | Over the counter (OTC) artificial tear drops for dry eye syndrome |
| Q24203616 | Over the counter (OTC) artificial tear drops for dry eye syndrome |
| Q33921185 | Oxidative stress induced age dependent meibomian gland dysfunction in Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice |
| Q36444344 | PERSIST: Physician's Evaluation of Restasis(®) Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review |
| Q35010238 | Patient reported differences in dry eye disease between men and women: impact, management, and patient satisfaction |
| Q47381165 | Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages. |
| Q47547213 | Prevalence and Risk Factors of self-reported dry eye in Brazil using a short symptom questionnaire |
| Q36537077 | Prevalence and associated factors of dry eye: Our experience in patients above 40 years of age at a Tertiary Care Center |
| Q45129629 | Prevalence and risk factors associated with dry eye syndrome among senior high school students in a county of Shandong Province, China |
| Q33964406 | Prevalence and risk factors of dry eye syndrome in a United States veterans affairs population |
| Q89598916 | Prevalence of Computer Vision Syndrome and Its Relationship with Ergonomic and Individual Factors in Presbyopic VDT Workers Using Progressive Addition Lenses |
| Q34438211 | Prevalence of and risk factors for dry eye symptom in mainland china: a systematic review and meta-analysis |
| Q99411668 | Prevalence of dry eye disease in the elderly: A protocol of systematic review and meta-analysis |
| Q51130489 | Proper balance of omega-3 and omega-6 fatty acid supplements with topical cyclosporine attenuated contact lens-related dry eye syndrome. |
| Q36779350 | Quantitative analysis of tear film fluorescence and discomfort during tear film instability and thinning |
| Q35591481 | Rasch analysis of the Ocular Surface Disease Index (OSDI) |
| Q50178476 | Reduced intraepithelial corneal nerve density and sensitivity accompany desiccating stress and aging in C57BL/6 mice. |
| Q52661549 | Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products. |
| Q41712693 | Regarding the influence of sex and aging on dry eye disease |
| Q89791440 | Regional Comparison of Goblet Cell Number and Area in Exposed and Covered Dry Eyes and Their Correlation with Tear MUC5AC |
| Q93092458 | Repeatability of Meibomian Gland Contrast, a Potential Indicator of Meibomian Gland Function |
| Q35934069 | Role of Matrix Metalloproteinases 2 and 9 in Lacrimal Gland Disease in Animal Models of Sjögren's Syndrome |
| Q35797137 | Role of epithelial-mesenchymal transition in repair of the lacrimal gland after experimentally induced injury |
| Q37739846 | Role of platelet-activating factor in cell death signaling in the cornea: A review |
| Q36617867 | Safety and comfort evaluation of a new formulation of Visine(®) lubricant eye drops containing HydroBlend™ and GentlePur™ |
| Q33825538 | Safety and efficacy of cyclosporine in the treatment of chronic dry eye. |
| Q42371417 | Scaling and maintenance of corneal thickness during aging. |
| Q38598996 | Sex differences in the effect of aging on dry eye disease |
| Q57059448 | Sex hormone therapy's effect on dry eye syndrome in postmenopausal women: A meta-analysis of randomized controlled trials |
| Q38201149 | Sex hormones and the dry eye. |
| Q37404304 | Single Nucleotide Polymorphisms in the BDNF, VDR, and DNASE 1 Genes in Dry Eye Disease Patients: A Case-Control Study |
| Q27342865 | SkQ1 Ophthalmic Solution for Dry Eye Treatment: Results of a Phase 2 Safety and Efficacy Clinical Study in the Environment and During Challenge in the Controlled Adverse Environment Model |
| Q37330361 | Sleep and mood disorders in women with dry eye disease |
| Q36812082 | Small-molecule CFTR activators increase tear secretion and prevent experimental dry eye disease |
| Q34070100 | Spatial epidemiology of dry eye disease: findings from South Korea |
| Q47134597 | Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye. |
| Q55174805 | Tear Volume-based Diagnostic Classification for Tear Dysfunction. |
| Q35570793 | Tear dysfunction and the cornea: LXVIII Edward Jackson Memorial Lecture |
| Q37641850 | Tear osmolarity and dry eye symptoms in diabetics. |
| Q36926074 | The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease |
| Q35831276 | The Effects of Increasing Ocular Surface Stimulation on Blinking and Tear Secretion |
| Q37689580 | The Human Eye Proteome Project: perspectives on an emerging proteome |
| Q35890926 | The Prevalence of Dry Eye Syndrome's and the Likelihood to Develop Sjögren's Syndrome in Taiwan: A Population-Based Study |
| Q41405231 | The Prospective Health Assessment of Cataract Patients' Ocular Surface (PHACO) study: the effect of dry eye. |
| Q48344821 | The Use of Topical Corticosteroids for Treatment of Dry Eye Syndrome. |
| Q33765579 | The application of in vivo laser scanning confocal microscopy as a tool of conjunctival in vivo cytology in the diagnosis of dry eye ocular surface disease. |
| Q91951530 | The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations |
| Q93046214 | The effect of acute exercise on environmentally induced symptoms of dry eye |
| Q37637160 | The effects of increasing ocular surface stimulation on blinking and sensation |
| Q34005463 | The effects of mild ocular surface stimulation and concentration on spontaneous blink parameters |
| Q39347374 | The function of regulatory T cells at the ocular surface: Review. |
| Q36590746 | The interblink interval in normal and dry eye subjects |
| Q34769303 | The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland |
| Q34769309 | The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD |
| Q38901538 | The potential role of neuropathic mechanisms in dry eye syndromes |
| Q21296673 | The role of medications in causing dry eye |
| Q26822610 | Therapeutic Strategies to Treat Dry Eye in an Aging Population |
| Q24201139 | Topical cyclosporine A therapy for dry eye syndrome |
| Q90093016 | Topical cyclosporine A therapy for dry eye syndrome |
| Q34206399 | Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial. |
| Q37460389 | Transcription, translation, and function of lubricin, a boundary lubricant, at the ocular surface |
| Q90511596 | Transcutaneous Electrical Nerve Stimulation for the Long-Term Treatment of Ocular Pain |
| Q55009490 | Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study. |
| Q57479267 | Validation of an Objective Measure of Dry Eye Severity |
| Q41615508 | [EXPRESS] Evidence that Dry Eye Represents a Chronic Overlapping Pain Condition. |
Search more.